Please login to the form below

Not currently logged in
Email:
Password:

booster jabs

This page shows the latest booster jabs news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s Vaxzevria trial provides further support for protection against COVID-19 variants

AstraZeneca’s Vaxzevria trial provides further support for protection against COVID-19 variants

New data from continued testing has shown that a third booster of Vaxzevria supports an increased antibody response against SARS-CoV-2 variants. ... data show that it has an important role to play as a third dose booster, including when used after other

Latest news

  • UK marks one-year anniversary of Oxford/AstraZeneca vaccine UK marks one-year anniversary of Oxford/AstraZeneca vaccine

    variant. Fronted by the government’s Get Boosted Now campaign, the booster jab roll-out saw a positive spike in vaccination rates during December 2021, with over 8 million jabs administered ... On Saturday 18 December, a new record was set by NHS

  • Booster plans expanded to combat Omicron Booster plans expanded to combat Omicron

    The UK government has also announced plans to expand the availability of booster jabs with new hospital hubsand pop-up centres, and by using 1, 500 community pharmacies. ... Over the past two weeks, Germany has expanded booster shots to all adults, while

  • US FDA expands COVID-19 booster jabs to all adults US FDA expands COVID-19 booster jabs to all adults

    of safety data from people who have already received a COVID-19 primary vaccine series and booster. ... Booster shots have demonstrated the ability to safely increase people’s protection against infection and severe outcomes.

  • UK expands COVID-19 vaccine plans as winter approaches UK expands COVID-19 vaccine plans as winter approaches

    The third dose, a booster jab, should be given six months after the second dose. ... The change of policy comes after results from the first real-world study on the effectiveness of the booster jabs were published by the UK Health Security Agency (UKHSA).

  • EU “still interested” in Valneva COVID vaccine despite UK snub EU “still interested” in Valneva COVID vaccine despite UK snub

    Negotiations between Valneva and the EU are “ongoing and advanced”, with its vaccine candidate VLA2001 touted as a potential booster shot in France. ... Data from the recent UK trial, Cov-Boost, which tested the effectiveness of several potential

More from news
Approximately 5 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...